ClinTec GmbH International And HCG Celebrate A Successful Partnership In Delivering Global Patient Recruitment Services At European Drug Conference, Drug Information Association

Glasgow, UK, 4 March 2010 — Dr Rabinder Buttar, PhD. President & CEO of ClinTec International and Frank S. Kilpatrick, President of Healthcare Communications Group (HCG), El Segundo, C A will celebrate their companies’ successful collaboration at the upcoming 22nd Annual Drug Information Association (DIA) EuroMeeting in Monaco on March 8-10, 2010. These clinical trial management firms have recently completed several successful global undertakings, “Our prompt ramp up in multiple study engagements is where we really shine,” stated Buttar, who touted the recent successful completion of the first portion of a 12-trial joint international osteoarthritis recruitment engagement spanning three continents. “It is impressive results like this that give us much to celebrate,” said Buttar. “We knew our two companies could together dramatically help our clients gain greater operational efficiencies while trimming recruitment timelines,” said Kilpatrick. He added that this constituted their largest global engagement thus far, borne of an exclusive partnership vision. The EuroMeeting event will be held at the Grimaldi Forum.

ClinTec provides immediate access to global patient recruitment services in over 40 countries, complementing HCGs strong base in the US. The union represents a perfect cohesion of U.S., European, Middle East, North African and Latin American interests according to HCG Senior Vice President, Jeanne Meadow. “All of our clients benefit from this relationship because our in-country teams expand our mutual reach,” said Meadows. Echoing this sentiment, Kilpatrick stated, “We don’t have to outsource because we have all the experts from scientific advisors to site specialists under one umbrella.” Together, ClinTec and HCG possess main offices, located in Glasgow, UK; Krakow, Poland; Bangalore, India; Beirut, Lebanon; Dubai, UAE; Philadelphia, US; and Los Angeles, US, along with ClinTec’s regional presence and registered offices in over 40 countries.

No strangers to DIA conferences around the world, ClinTec leadership has attended prior meetings in Budapest, Vienna, Prague, and Paris, among others. Their excitement regarding the upcoming DIA EuroMeeting in Monaco is high, It’s a fantastic opportunity to develop existing relationships and forge new ones at Euro DIA, there is no better medium than face to face contact for this” stated Buttar. Alongside ClinTec and HCG leadership, will be their senior team members to reach out to all DIA attendees during and after conference events. “This is where European pharmaceutical leadership meets and has proved invaluable to our global expansion,” said Meadow.

The collaboration of ClinTec and HCG initially focused on recruitment and retention services for their clients, but has been rapidly expanding. “We are receiving acknowledgement for our efforts and that has produced enquiries into our other core competencies and services, including global feasibility, site selection and study management process improvement,” said Buttar. “We’re pleased to have received the attention of some of pharma’s biggest and most innovative companies and are solidly committed to advancing their clinical opportunities,” stated Buttar. As the ClinTec and HCG teams celebrate their mutual accomplishments, their leadership welcomes the opportunity to celebrate this success with the event attendees, “There are several significant trends underway globally that influence recruitment and we’d like to share our findings and make Global Patient Recruitment Services accessible to all companies in every region of the world. For information on event registration: www.diahome.org. Photos available upon request.

About ClinTec International

ClinTec International is a global contract clinical research organisation, established in 1997 by Dr Rabinder Buttar, the company’s President and CEO. ClinTec International has a presence in 40 developed and emerging countries, covering Western Europe, Central & Eastern Europe, the Middle East and North Africa, Central and South Africa, Latin America, India and the US.

In addition to ClinTec International’s vast expertise in oncology, the organisation has also conducted over 150 clinical trials in other therapeutic areas including anti-infectives, cardiology, dermatology, gastroenterology, neurology, respiratory medicine and rheumatology. ClinTec International excels in conducting clinical studies in diverse geographical locations, supported by a team of world-class project managers and clinical research associates. ClinTec International’s „fast, flexible and focused? approach to clinical research ensures an added advantage to the drug development process. The organisations range of services includes Clinical Monitoring and Project Management, Regulatory Affairs, Medical Writing, Data Management and Biostatistics, Global Clinical Resourcing, Quality Assurance, Drug Development Consultancy and Clinical Training courses.

For further information please contact:

Bobby Bal, Senior Director Corporate Development, ClinTec International Headquarters: +44 (0) 141 226 1120 or bbal@clintec.com

For more information about ClinTec, please visit www.clintec.com.

About Healthcare Communications Group (“HCG”)

HCG is an integrated clinical trial consulting and marketing firm. HCG clinical trial services partners with major pharmaceutical and biotechnology companies to enable strategic recruitment and retention of patients to participate in global clinical research studies for potentially new life-saving medicines and medical devices. HCG focuses 100 percent of its efforts on patient enrollment and compliance and is a proven leader in the subject recruitment field, having refined analytical models to assess feasibility and direct efforts toward timely clinical trial completion. HCG derives its insights from first-party sources, our database of 8,000 investigator sites, prior study experiences and our KOL network. HCG’s international “turnkey” recruitment expertise spans the full range of clinical therapeutic areas, from acute diseases to chronic afflictions. Our services include feasibility planning, competitive trial analysis, research study “branding”, subject/principal investigator motivational research, television, radio and print advertising, public relations, “grassroots” community outreach initiatives, and patient/professional education. The company has served seven of the top 10 pharmaceutical companies since 1998. For more information about Healthcare Communications Group, please visit www.hcg.com.